Trial Profile
Control of efficacy and tolerability of Ketilept therapy in acute episodes of schizophrenia and schizoaffective disorder in a multicentre, open, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2011 New trial record